RDUS

Radius Health Inc
35.71 USD
+0.32 +0.904%
1m
5m
15m
30m
1H
4H
1D
1W
  • Full Name Radius Health Inc
  • Currency USD
  • Spread Type Floating
  • Margin 20%
  • Min traded quantity 10
  • Trading hours Mon - Fri 13:30 - 20:00 (UTC)
  • Long position overnight fee -0.0145%
  • Short position overnight fee -0.0077%
  • Overnight fee time 00:00 AM
  • Derivative Type Contract for Difference

Radius Health Inc

Radius (RDUS) is a biopharmaceutical company engaged in innovative development, with a special focus on oncology, osteoporosis and endocrine diseases. The company was founded in 2003. With offices in Waltham, Cambridge, Parsippany, Massachusetts, New Jersey and Wayne, Radius is now engaged in developing a selective estrogen receptor degrader called RAD1901. Also, the company works on RAD140, an investigational selective androgen receptor modulator drug. Radius Health is traded on the NASDAQ stock exchange and the company is headquartered in Waltham, USA.
Ready to get started?
Send me the link to download Capital.com app. Download Capital.com